Residual pulmonary hypertension in children after treatment with inhaled nitric oxide: A follow-up study regarding cardiopulmonary and neurological symptoms

Acta Paediatrica, International Journal of Paediatrics

Volumn 89, Issue 12, 2000, Pages 1414-1419

  Gothberg S ^a   Edberg, K E ^a   Tang, S F ^b   Michelsen, S ^c   Winberg, P ^d   Holmgren, D ^a   Miller, O ^b   Thaulow, E ^c   Lonnqvist P A ^d  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute respiratory failure; Children; Congenital heart defect; Follow up; Inhaled nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ACUTE RESPIRATORY FAILURE; ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ECHOCARDIOGRAPHY; EVALUATION; HEART DISEASE; HUMAN; HYPOXEMIA; INFANT; INHALATION ANESTHESIA; INTENSIVE CARE; LUNG DISEASE; MINIMAL RESIDUAL DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; PULMONARY HYPERTENSION; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VASODILATATION;

ADMINISTRATION, INHALATION; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; NITRIC OXIDE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; VASODILATOR AGENTS;

EID: 0034509976     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352500456561     Document Type: Article

References (38)

1. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension
2. Vascular components of ARDS. Clinical pulmonary hemodynamics and morphology
3. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary haemodynamics
4. Pulmonary hypertensive crises following surgery for congenital heart defects in young children
5. Nitric oxide activity in patients undergoing cardiopulmonary bypass
6. Time course of endothelin-1 and nitrate anion levels after cardiopulmonary bypass in congenital heart defects
7. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass
8. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
9. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
10. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardio-pulmonary bypass
11. Very-low-dose inhaled nitric oxide: A selective pulmonary vasodilator after operations for congenital heart disease
12. Inhaled nitric oxide to newborns and infants after congenital heart surgery on cardiopulmonary bypass: A dose-response study
13. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
14. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure
15. DNA damage and mutation in human cells exposed to nitric oxide in vitro
16. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome
17. Nitric oxide, a novel neuronal messenger
18. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide
19. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure
20. Rebound pulmonary hypertension after inhalation of nitric oxide
21. Morbid anatomical changes in the lungs of dogs after inhalation of higher oxides of nitrogen during anaesthesia
22. Nitric oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods
23. Ultrastructural changes of the rabbit lung after 5 ppm nitric oxide exposure
24. Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn
25. The outcome of very low birth weight neonates (≤1500 g) rescued by inhaled nitric oxide: Neurodevelopment in early childhood
26. Cardiac surgery and inhaled nitric oxide: Indication and follow-up (2-4 years)
27. Persistent pulmonary hypertension of the newborn (PPHN) treated with inhaled nitric oxide: Preliminary hearing outcomes
28. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension
29. Routine developmental examination in normal and retarded children
30. Pattern analysis of motor development and its disorders
31. Timing of recovery of lung function after severe hypoxemic respiratory failure in children
32. Respiratory and cardiac function in children after acute hypoxemic respiratory failure
33. Long-term pulmonary sequelae of meconium aspiration syndrome
34. Neonatal meconium aspiration syndrome and respiratory morbidity during infancy
35. Late pulmonary sequelae of bronchopulmonary dysplasia
36. Lung function eight years after neonatal ventilation
37. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
38. The infant motor screen